Beam Therapeutics Inc. (BEAM) Q4 2025 Earnings Call Transcript
Source: SeekingAlpha
2026-02-24 16:57:55 ET
Beam Therapeutics Inc. (BEAM) Q4 2025 Earnings Call February 24, 2026 8:00 AM EST...
Read the full article on Seeking Alpha
For further details see:
Beam Therapeutics Inc. (BEAM) Q4 2025 Earnings Call Transcript
Beam Therapeutics Inc.
NASDAQ: BEAM
BEAM Trading
-6.76% G/L:
$22.2291 Last:
1,021,330 Volume:
$23.46 Open:
BEAM Latest News
March 26, 2026 11:52:58 pm
Beam Therapeutics Targets Accelerated Approval in Rare Disease AATD as Base Editing Data Exceed Key Threshold
March 25, 2026 07:00:00 am
Beam Therapeutics Announces Compelling Updated Clinical Data from the Ongoing Phase 1/2 Trial of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) to Support Advancement to Pivotal Development
February 24, 2026 07:01:00 am
Beam Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Announces New Liver-Targeted Genetic Disease Program in Phenylketonuria (PKU)
February 24, 2026 07:00:00 am
Beam Therapeutics Announces $500 Million Strategic Financing Facility with Sixth Street
BEAM Stock Data
$2,726,631,745
90,820,075
0.13%
130
N/A
Biotechnology & Life Sciences
Healthcare
US
Cambridge
